IDO1 and neoplasm: Upregulation of IDO in tumor cells or antigen-presenting cells leads to Trp depletion and accumulation of its downstream catabolite Kyn in the local tumor microenvironment (TME), resulting in immunosuppression by inducing T cell anergy and apoptosis and suppressing T cell differentiation (1–3, 6–9).